Article info

Download PDFPDF
Immunosuppressants and/or antivascular endothelial growth factor inhibitors in punctate inner choroidopathy? Follow-up results with optical coherence tomography angiography

Authors

  • Dominika Pohlmann Department of Ophthalmology, Charité – Universitätsmedizin Berlin,corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Uwe Pleyer Department of Ophthalmology, Charité – Universitätsmedizin Berlin,corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Antonia M Joussen Department of Ophthalmology, Charité – Universitätsmedizin Berlin,corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Sibylle Winterhalter Department of Ophthalmology, Charité – Universitätsmedizin Berlin,corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dominika Pohlmann, Department of Ophthalmology, Charité – University Medicine Berlin, Berlin 13353, Germany; dominika.pohlmann{at}charite.de
View Full Text

Citation

Pohlmann D, Pleyer U, Joussen AM, et al
Immunosuppressants and/or antivascular endothelial growth factor inhibitors in punctate inner choroidopathy? Follow-up results with optical coherence tomography angiography

Publication history

  • Received April 23, 2018
  • Revised September 9, 2018
  • Accepted September 12, 2018
  • First published October 18, 2018.
Online issue publication 
July 25, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.